ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: PUB295

Misleading IL-18 Elevation in Sarcoidosis: Renal Cell Carcinoma Masquerading as Renal Sarcoidosis

Session Information

Category: Onconephrology

  • 1700 Onconephrology

Authors

  • Abdelgadir, Yasir, Mayo Foundation for Medical Education and Research, Rochester, Minnesota, United States
  • Thongprayoon, Charat, Mayo Foundation for Medical Education and Research, Rochester, Minnesota, United States
  • Abdelgadir, Eman, Mayo Foundation for Medical Education and Research, Rochester, Minnesota, United States
  • Cheungpasitporn, Wisit, Mayo Foundation for Medical Education and Research, Rochester, Minnesota, United States
Introduction

Interleukin-18 (IL-18) is a proinflammatory cytokine within the interleukin-1 family, playing a key role in both innate and adaptive immunity through the stimulation of interferon-gamma (IFN-γ). Elevated IL-18 levels have been associated with inflammatory and autoimmune diseases, including Sarcoidosis. Moreover, elevated IL-18 has been observed in certain malignancies, including renal cell carcinoma (RCC). This case highlights the diagnostic challenge of elevated IL-18 in a patient with both sarcoidosis and a renal mass.

Case Description

A 67-year-old man with a history of diabetes mellitus, chronic kidney disease stage G3a, pulmonary sarcoidosis, and prostate cancer underwent surveillance PET-CT, which revealed an incidental 5.2 cm solid left kidney mass, that was confrimed on A CT. Cytokine profile demonstrated a markedly elevated IL-18 level of 819 pg/mL, other cytokines were normal. Given the elevated IL-18 both urology and pulmonary teams initially suspected a sarcoid-related granulomatous inflammation. Accordingly, the patient was referred to nephrology for preoperative renal function assessment and evaluation of possible renal sarcoidosis. Laboratory testing showed stable kidney function with a serum creatinine of 1.4 mg/dL consistent with his baseline. Despite the working impression of renal sarcoidosis, concern for malignancy persisted due to the size and radiologic features of the lesion. A DMSA renal scan demonstrated symmetric function (49% right, 51% left), and the patient proceeded with left radical nephrectomy.

Discussion

Histopathology confirmed papillary RCC, with no histologic evidence of sarcoidosis. Postoperatively, the patient’s serum creatinine peaked at 2.58 mg/dL but gradually improved to a nadir of 1.13 mg/dL without the need for dialysis.
IL-18 is a pro-inflammatory cytokine involved in Th1 activation and IFN-γ production, commonly elevated in sarcoidosis. It is also elevated in malignancies such as RCC, where it may correlate with tumor progression and prognosis. In this case, despite elevated IL-18 and a history of sarcoidosis, the renal mass was ultimately diagnosed as papillary RCC. This highlights the importance of interpreting IL-18 within a comprehensive clinical context—alongside imaging and histopathology—to avoid misdiagnosis and ensure appropriate management.

Digital Object Identifier (DOI)